Kang WJ - Search Results

1

Using (18)F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia.

Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH, Yun M, Lee JD, Kang WJ. Seo HJ, et al. Among authors: kang wj. Nucl Med Mol Imaging. 2011 Sep;45(3):233-7. doi: 10.1007/s13139-011-0095-7. Epub 2011 Jul 14. Nucl Med Mol Imaging. 2011. PMID: 24900011 Free PMC article.

2

Dosimetry in leakage of (188)Re-DTPA during intracoronary balloon brachytherapy.

Paeng JC, Lee DS, Kang WJ, Yang HM, Chung JK, Jeong JM, Chae IH, Lee MM, Lee MC. Paeng JC, et al. Among authors: kang wj. Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1263-5. doi: 10.1007/s00259-003-1235-9. Epub 2003 Jun 13. Eur J Nucl Med Mol Imaging. 2003. PMID: 12811423

3

Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.

Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Kang WJ, et al. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):202-7. doi: 10.1007/s00259-003-1368-x. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129702 Clinical Trial.

4

Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.

Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP. Chung HH, et al. Among authors: kang wj, kang sb. Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):480-6. doi: 10.1007/s00259-006-0260-x. Epub 2006 Nov 7. Eur J Nucl Med Mol Imaging. 2007. PMID: 17089122 Clinical Trial.

5

The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.

Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB. Chung HH, et al. Among authors: kang wj, kang sb. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1081-8. doi: 10.1007/s00259-007-0687-8. Epub 2008 Jan 8. Eur J Nucl Med Mol Imaging. 2008. PMID: 18180917

6

18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.

Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, Kang WJ. Lee JW, et al. Among authors: kang wj. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1794-802. doi: 10.1007/s00259-009-1155-4. Epub 2009 May 9. Eur J Nucl Med Mol Imaging. 2009. PMID: 19430783 Clinical Trial.

7

Fluorine-18-FDG PET findings of focal eosinophilic liver disease: correlation with CT and/or MRI, laboratory, and pathologic findings.

Kim WH, Kim SH, Kim YH, Youn SH, Kang WJ, Kim MA, Han JK, Choi BI. Kim WH, et al. Among authors: kang wj. Abdom Imaging. 2010 Aug;35(4):437-46. doi: 10.1007/s00261-009-9513-z. Epub 2009 Jun 11. Abdom Imaging. 2010. PMID: 19517160

8

Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.

Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, Lee JD. Ahn KJ, et al. Among authors: kang wj. J Nucl Med. 2009 Sep;50(9):1525-32. doi: 10.2967/jnumed.108.060780. Epub 2009 Aug 18. J Nucl Med. 2009. PMID: 19690031 Free article.

9

Multiplex imaging of single tumor cells using quantum-dot-conjugated aptamers.

Kang WJ, Chae JR, Cho YL, Lee JD, Kim S. Kang WJ, et al. Small. 2009 Nov;5(22):2519-22. doi: 10.1002/smll.200900848. Small. 2009. PMID: 19714733 No abstract available.

10

Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.

Cho A, Hur J, Kang WJ, Cho HJ, Lee JH, Yun M, Lee JD. Cho A, et al. Among authors: kang wj. Eur Radiol. 2011 May;21(5):1077-87. doi: 10.1007/s00330-010-2006-1. Epub 2010 Nov 27. Eur Radiol. 2011. PMID: 21113598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters